CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-07 | White Albert G III Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2025-03-07 | Malik Vikram Director | Grant or award | +7,364 | 253,878 | ||
| 2025-03-07 | Malik Vikram Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2025-03-07 | Parschauer Karah Herdman Director | Grant or award | +7,364 | 45,071 | ||
| 2025-03-07 | Parschauer Karah Herdman Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2024-12-23 | Avelar Rui See Remarks | Sale 10b5-1 | −2,252 | $10.85 | $24K | 366,595 |
| 2024-12-23 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −1,586 | $10.85 | $17K | 146,916 |
| 2024-12-23 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −10,502 | $10.85 | $114K | 522,847 |
| 2024-09-06 | Beaver Sandra Chief Financial Officer | Sale | −3,276 | $14.98 | $49K | 148,502 |
| 2024-08-30 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Sale | −5,631 | $15.85 | $89K | 82,375 |
| 2024-07-01 | White Albert G III Director | Grant or award | +23,014 | 23,014 | ||
| 2024-06-06 | MOATAZEDI DAVID See Remarks | Option exercise | +175,940 | $7.28 | $1.3M | 709,289 |
| 2024-06-06 | MOATAZEDI DAVID See Remarks | Sale | −175,940 | $12.59 | $2.2M | 533,349 |
| 2024-06-06 | MOATAZEDI DAVID See Remarks | Option exercise · Stock Option (Right to Buy) | −175,940 | 1,006,079 | ||
| 2024-06-05 | MOATAZEDI DAVID See Remarks | Option exercise | +155,278 | $5.46 | $848K | 688,627 |
| 2024-06-05 | MOATAZEDI DAVID See Remarks | Sale | −155,278 | $12.92 | $2.0M | 533,349 |
| 2024-06-05 | MOATAZEDI DAVID See Remarks | Option exercise · Stock Option (Right to Buy) | −155,278 | 155,281 | ||
| 2024-06-04 | MOATAZEDI DAVID See Remarks | Sale | −140,214 | $12.73 | $1.8M | 533,349 |
| 2024-06-03 | Malik Vikram Director | Sale | −7,500 | $12.96 | $97K | 246,514 |
| 2024-05-14 | GILL DAVID N Director | Sale | −6,718 | $12.60 | $85K | 33,964 |
Page 4 of 16 · 303 trades